Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.50 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 4/20 | 0.41 |
| ▸ | CCR2 | P41597 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3629217 | 1.00 | EP300 (0.50) | EP300ZDHHC7EPHX1FAAHCCR2 | |
| SCHEMBL4242345 | 1.00 | EP300 (0.50) | EP300ZDHHC7EPHX1FAAHCCR2 | |
| SCHEMBL17448533 | 1.00 | EP300 (0.50) | EP300ZDHHC7EPHX1FAAHCCR2 | |
| SCHEMBL3023651 | 1.00 | EP300 (0.50) | EP300ZDHHC7EPHX1FAAHCCR2 | |
| SCHEMBL3033834 | 1.00 | EP300 (0.50) | EP300ZDHHC7EPHX1FAAHCCR2 | |
| SCHEMBL10991246 | 1.00 | EP300 (0.50) | EP300ZDHHC7EPHX1FAAHCCR2 | |
| SCHEMBL18301068 | 1.00 | EP300 (0.50) | EP300ZDHHC7EPHX1FAAHCCR2 | |
| SCHEMBL16583215 | 1.00 | EP300 (0.50) | EP300ZDHHC7EPHX1FAAHCCR2 | |
| SCHEMBL2509676 | 1.00 | EP300 (0.50) | EP300ZDHHC7EPHX1FAAHCCR2 | |
| SCHEMBL26112756 | 1.00 | EP300 (0.50) | EP300ZDHHC7EPHX1FAAHCCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692226-A1 | SOLUTION, DISPERSANT, METHOD FOR PRODUCING VINYL COMPOUND POLYMER, AND METHOD FOR PRODUCING SOLUTION | Kuraray Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-4674910-A1 | COMPOSITION COMPRISING VINYL ALCOHOL-BASED POLYMER, AND METHOD FOR SEPARATING VINYL ALCOHOL-BASED POLYMER | Kuraray Co., Ltd. (JP) | 2026-01-07 | — | — | EP | disclosed |
| CN-119970539-A | Active ingredient dissolving composition | 苏州元素集化学工业有限公司 | 2025-05-13 | — | — | CN | disclosed |
| WO-2023182120-A1 | DISPERSION AND LUBRICANT COMPOSITION | DIC株式会社 | 2023-09-28 | — | — | WO | disclosed |
| CN-108635240-B | Dispersion liquid and hydrogel forming method | 日产化学工业株式会社 | 2021-09-14 | — | — | CN | disclosed |
| US-20200138695-A1 | COSMETIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2020-05-07 | — | — | US | disclosed |
| EP-3616683-A1 | COSMETIC COMPOSITION | Rohto Pharmaceutical Co., Ltd. (JP) | 2020-03-04 | — | — | EP | disclosed |
| CN-110621295-A | Cosmetic composition | 日本乐敦制药株式会社 | 2019-12-27 | — | — | CN | disclosed |
| US-10421055-B2 | Dispersion and method for forming hydrogel | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-09-24 | — | — | US | disclosed |
| EP-3296013-A1 | DISPERSION AND METHOD FOR FORMING HYDROGEL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-03-21 | — | — | EP | disclosed |
| EP-2865442-B1 | LIQUID DISPERSION AND FORMATION METHOD FOR HYDROGELS | NISSAN CHEMICAL IND LTD (JP) | 2017-12-06 | — | — | EP | disclosed |
| CN-102574962-B | Curable resin composition | DENKA Co.,Ltd. (JP) | 2016-05-04 | — | — | CN | disclosed |
| US-20150202586-A1 | DISPERSION AND METHOD FOR FORMING HYDROGEL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-07-23 | — | — | US | disclosed |
| EP-2865442-A1 | DISPERSION LIQUID AND HYDROGEL FORMATION METHOD | Nissan Chemical Industries, Ltd. (JP) | 2015-04-29 | — | — | EP | disclosed |
| EP-1156033-B1 | PROCESS FOR PRODUCING ACIDIC N-(LONG-CHAIN ACYL)AMINO ACID | ASAHI CHEMICAL IND (JP) | 2011-12-07 | — | — | EP | disclosed |
| US-20100215603-A1 | Body Surface Protecting Composition | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-1891924-A1 | COMPOSITION FOR PROTECTION OF BODY SURFACE | Asahi Kasei Chemicals Corporation (JP) | 2008-02-27 | — | — | EP | disclosed |
| US-6569829-B1 | Removing impurities from a long chain N-acyl acidic amino acid such as N-lauroyl-L-glutamic acid containing an inorganic salt by solvent extraction using a solution of water and tert-butanol; use in cosmetics and detergents | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2003-05-27 | — | — | US | disclosed |
| EP-1156033-A1 | PROCESS FOR PRODUCING ACIDIC N-(LONG-CHAIN ACYL)AMINO ACID | Asahi Kasei Kabushiki Kaisha (JP) | 2001-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200138695-A1 | COSMETIC COMPOSITION | CUTA, LAGE3, SMURF1 | EP300 995/4885ZDHHC7 1583/4885EPHX1 4254/4885 |
| US-20100215603-A1 | Body Surface Protecting Composition | FABP2, CUTA, FABP1 | EP300 2099/4885ZDHHC7 930/4885EPHX1 1753/4885 |
| US-10421055-B2 | Dispersion and method for forming hydrogel | ABHD6, PLOD3, LIPC | EP300 1099/4885ZDHHC7 311/4885EPHX1 1211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.